Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomised Trial of Two Versus Three Doses of Human Papillomavirus (HPV) Vaccine in India
Brief Summary: The primary study hypothesis wasthat a two-dose human papillomavirus (HPV) vaccine regimen would offer similar immunogenicity and protection as that of a three-dose regimen to girls against persistent HPV infection and cervical neoplasia caused by HPV types included in the vaccine. The Government of India stopped vaccination in all the HPV vaccine trials in the country in April 2010 due to reasons not related to this study.


Options:
A: Intervention Type: BIOLOGICAL; Name: HPV 16/18 VLP AS04; Assigned to Arm(s): N/A
B: Arm Label: 3-dose; Type: ACTIVE_COMPARATOR; Interventions: Biological: Prophylactic quadrivalent HPV vaccine Merck (Gardasil®) | Arm Label: 2-dose; Type: EXPERIMENTAL; Interventions: Biological: Prophylactic quadrivalent HPV vaccine Merck (Gardasil®) | Arm Label: 2 doses by default; Type: EXPERIMENTAL; Interventions: Biological: Prophylactic quadrivalent HPV vaccine Merck (Gardasil®) | Arm Label: Single-dose; Type: EXPERIMENTAL; Interventions: Biological: Prophylactic quadrivalent HPV vaccine Merck (Gardasil®) | Arm Label: Unvaccinated; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BIOLOGICAL; Name: Prophylactic quadrivalent HPV vaccine Merck (Gardasil®); Assigned to Arm(s): 2 doses by default, 2-dose, 3-dose, Single-dose
C: Arm Label: Cervarix + Boostrix/Menactra Group; Type: EXPERIMENTAL; Interventions: Biological: Different formulations of GSK Biologicals' HPV vaccine (580299), Biological: Menactra TM, Biological: Boostrix TM | Arm Label: Cervarix + Menactra/Boostrix Group; Type: EXPERIMENTAL; Interventions: Biological: Different formulations of GSK Biologicals' HPV vaccine (580299), Biological: Menactra TM, Biological: Boostrix TM | Arm Label: Cervarix + Boostrix + Menactra Group; Type: EXPERIMENTAL; Interventions: Biological: Different formulations of GSK Biologicals' HPV vaccine (580299), Biological: Menactra TM, Biological: Boostrix TM | Arm Label: Boostrix/Cervarix Group; Type: EXPERIMENTAL; Interventions: Biological: Different formulations of GSK Biologicals' HPV vaccine (580299), Biological: Menactra TM, Biological: Boostrix TM | Arm Label: Menactra/Cervarix Group; Type: EXPERIMENTAL; Interventions: Biological: Different formulations of GSK Biologicals' HPV vaccine (580299), Biological: Menactra TM | Arm Label: Cervarix Group; Type: EXPERIMENTAL; Interventions: Biological: Different formulations of GSK Biologicals' HPV vaccine (580299) | Intervention Type: BIOLOGICAL; Name: Different formulations of GSK Biologicals' HPV vaccine (580299); Assigned to Arm(s): Boostrix/Cervarix Group, Cervarix + Boostrix + Menactra Group, Cervarix + Boostrix/Menactra Group, Cervarix + Menactra/Boostrix Group, Cervarix Group, Menactra/Cervarix Group | Intervention Type: BIOLOGICAL; Name: Menactra TM; Assigned to Arm(s): Boostrix/Cervarix Group, Cervarix + Boostrix + Menactra Group, Cervarix + Boostrix/Menactra Group, Cervarix + Menactra/Boostrix Group, Menactra/Cervarix Group | Intervention Type: BIOLOGICAL; Name: Boostrix TM; Assigned to Arm(s): Boostrix/Cervarix Group, Cervarix + Boostrix + Menactra Group, Cervarix + Boostrix/Menactra Group, Cervarix + Menactra/Boostrix Group
D: Arm Label: Patients; Type: OTHER; Interventions: Other: Human papilloma virus vaccine (cervarix) | Intervention Type: OTHER; Name: Human papilloma virus vaccine (cervarix); Assigned to Arm(s): Patients

Answer: B